Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Dec 31, 2024
Grant Date -
Mar 17, 2022
app pub date -
Dec 13, 2019
filing date -
Dec 13, 2019
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein are compounds of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which Ring A, Ring B, Ring C, R1, R2, L, Y, and W have the meanings given in the specification, which are inhibitors of FGFR1, FGFR2, FGFR3 and/or FGFR4 and are useful in the treatment and prevention of diseases which can be treated with an FGFR inhibitor, including diseases or disorders mediated by FGFR1, FGFR2, FGFR3 and/or FGFR4.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully